The Department of Health has recorded 14,907 dengue cases as of February 14, which is 70 percent lower than the same period last year. Officials credit the decline to stronger prevention measures, early consultation, surveillance, and clinical management. They remind the public to stay vigilant as cases could rise.
On February 27, 2026, the Department of Health (DOH) reported 14,907 dengue cases as of February 14. This figure is 70 percent lower compared to the same period last year, according to Health Undersecretary Gloria Balboa.
Speaking at the Philippine Medical Association (PMA)’s “End Dengue Coalition” event in Quezon City, Balboa attributed the decline to stronger prevention measures, early consultation, surveillance, and clinical management. She reminded the public to remain vigilant as dengue cases could rise.
“Dengue is all-year round, but has its peak cycles that include the July to October period,” said Eric Tayag, a former health undersecretary and part of the PMA ad hoc committee on dengue advocacy. Based on DOH data, 45 percent of dengue cases in 2025 were recorded from July to October, Tayag noted.
Lulu Bravo, another member of the ad hoc committee, stressed the need for new interventions, such as vaccination, to prevent dengue. After the Dengvaxia vaccine controversy in 2015, the country still has no widely available dengue vaccine approved by the Food and Drug Administration (FDA). Japan-based Takeda Pharmaceuticals’ second-generation dengue vaccine Qdenga, despite compliance with FDA requirements, remains under review.
